Vaccine Uptake in the US After Full Food and Drug Administration Approval of the BNT162b2 mRNA COVID-19 Vaccine

This cross-sectional study examines the association of full approval of the BNT162b2 mRNA vaccine by the US Food and Drug Administration (FDA) with subsequent US uptake of COVID-19 vaccines of any kind.

Detalles Bibliográficos
Autores principales: Bailey, Elise Vandersteen, Wilson, Fernando A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987898/
https://www.ncbi.nlm.nih.gov/pubmed/35385093
http://dx.doi.org/10.1001/jamanetworkopen.2022.6108
Descripción
Sumario:This cross-sectional study examines the association of full approval of the BNT162b2 mRNA vaccine by the US Food and Drug Administration (FDA) with subsequent US uptake of COVID-19 vaccines of any kind.

Ejemplares similares